Clinical trial
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV…
NCT00003262 · Centro di Riferimento Oncologico - Aviano, Other · Unknown status
Key facts
| NCT number | NCT00003262 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection |
| Official title | Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: "Stanford V Regimen" For "Low Risk" Patients, "EBVP Regimen" For "High Risk" Patients |
| Lead sponsor | Centro di Riferimento Oncologico - Aviano, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, filgrastim, Stanford V regimen, doxorubicin hydrochloride, epirubicin hydrochloride, etoposide, mechlorethamine hydrochloride, prednisone, vinblastine sulfate, vincristine sulfate |
| Enrollment | 30 |
| Start date | May 1, 1997 |
| First posted | Apr 23, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: